BAZAN RUSSO, Tancredi Didier
 Distribuzione geografica
Continente #
EU - Europa 1.230
NA - Nord America 983
AS - Asia 953
SA - Sud America 163
AF - Africa 37
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.373
Nazione #
US - Stati Uniti d'America 932
RU - Federazione Russa 424
SG - Singapore 373
IT - Italia 328
CN - Cina 194
DE - Germania 148
BR - Brasile 130
FI - Finlandia 112
VN - Vietnam 99
HK - Hong Kong 79
FR - Francia 67
BD - Bangladesh 62
PL - Polonia 60
JP - Giappone 34
IN - India 29
GB - Regno Unito 28
CA - Canada 24
NL - Olanda 22
IQ - Iraq 17
AR - Argentina 13
KR - Corea 12
MX - Messico 12
ZA - Sudafrica 10
AT - Austria 9
ES - Italia 7
KE - Kenya 7
TR - Turchia 7
IE - Irlanda 6
PK - Pakistan 6
SA - Arabia Saudita 6
AU - Australia 5
CI - Costa d'Avorio 5
EG - Egitto 5
JM - Giamaica 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
IR - Iran 4
MA - Marocco 4
MY - Malesia 4
VE - Venezuela 4
LT - Lituania 3
MM - Myanmar 3
NP - Nepal 3
PE - Perù 3
SE - Svezia 3
UY - Uruguay 3
UZ - Uzbekistan 3
BO - Bolivia 2
CO - Colombia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
ID - Indonesia 2
LV - Lettonia 2
PS - Palestinian Territory 2
PT - Portogallo 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UA - Ucraina 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
NG - Nigeria 1
PA - Panama 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
TO - Tonga 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.373
Città #
Singapore 227
Ashburn 203
San Jose 150
Palermo 97
Munich 86
Moscow 85
Helsinki 84
Hong Kong 69
Rome 59
The Dalles 54
Zgierz 51
Dallas 46
Beijing 38
Los Angeles 36
Hefei 35
New York 33
Ho Chi Minh City 32
Tokyo 31
Hanoi 26
Council Bluffs 25
Lauterbourg 25
Santa Clara 25
Frankfurt am Main 24
Chicago 21
Buffalo 15
Lappeenranta 15
São Paulo 14
Orem 11
Boardman 10
Milan 10
Redondo Beach 10
Atlanta 9
Nuremberg 9
Denver 8
Houston 8
London 8
Warsaw 8
Chennai 7
Memphis 7
Mexico City 7
Montreal 7
Seoul 7
Volla 7
Baghdad 6
Johannesburg 6
Mumbai 6
Nairobi 6
Paris 6
Salt Lake City 6
Tappahannock 6
Abidjan 5
Bexley 5
Boston 5
Haiphong 5
Ludwigshafen am Rhein 5
Messina 5
New Delhi 5
Rio de Janeiro 5
Roubaix 5
Turin 5
Turku 5
Biên Hòa 4
Bắc Giang 4
Cairo 4
Curitiba 4
Erbil 4
Jyväskylä 4
Melbourne 4
Monza 4
Naples 4
Philadelphia 4
Toronto 4
Vienna 4
Brasília 3
Brooklyn 3
Campinas 3
Casamassima 3
Da Nang 3
Dammam 3
Dhaka 3
Dublin 3
Falkenstein 3
Guarulhos 3
Hải Dương 3
Jacksonville 3
Legnano 3
Lima 3
Manchester 3
Montevideo 3
Phoenix 3
Querétaro 3
Quito 3
Rancho Palos Verdes 3
San Francisco 3
Shanghai 3
Shenzhen 3
Tampa 3
Tashkent 3
Albignasego 2
Ankara 2
Totale 1.963
Nome #
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study 319
Exploring the potential of multiomics liquid biopsy testing in the clinical setting of lung cancer 182
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? 178
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay 162
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer 157
Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one? 157
Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. “Re-discovering the neglected biosources of the liquid biopsy family” 152
On-treatment dynamics of circulating extracellular vesicles in the first-line setting of patients with advanced non-small cell lung cancer: the LEXOVE prospective study. 148
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study 146
Applications of Platelet Concentrates (PCs) in Regenerative Onco-Urology: A Systematic Review of Literature 143
Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients 140
BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants? 136
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer? 134
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD) 130
Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints 125
The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors 123
Scientific Communication and oncology – "The bridge between knowledge and patients" 122
Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors 119
Potential Applications of PRP-Enhanced Polybutylene Succinate Graft as Vascular Access for Chemotherapy in Oncological Patients: A Systematic Review 115
Recent advances in liquid biopsy for precision oncology: emerging biomarkers and clinical applications in lung cancer 110
The role of bone modifying agents for secondary osteoporosis prevention and pain control in post-menopausal osteopenic breast cancer patients undergoing adjuvant aromatase inhibitors 109
Homologous recombination repair genetic testing variables and diagnostic paths for prostate cancer patients: a multicenter cohort study 93
Genomics and the early diagnosis of lung cancer 82
POLE-mutated endometrial cancer: new perspectives on the horizon? 78
Smaller, Cheaper, Faster: Where Next for Liquid Biopsies? 72
Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancer 50
Recent advances in the use of liquid biopsy for the diagnosis and treatment of lung cancer 50
Totale 3.532
Categoria #
all - tutte 10.320
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.320


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202322 0 0 0 0 0 1 7 7 2 1 3 1
2023/2024144 1 5 5 6 22 36 20 6 5 16 2 20
2024/2025883 30 36 66 40 41 76 153 77 55 119 103 87
2025/20262.452 185 91 188 233 249 397 341 224 181 124 113 126
2026/202731 31 0 0 0 0 0 0 0 0 0 0 0
Totale 3.532